Caris Life Sciences

(NASDAQ) CAI

Current Price$18.63

Market Cap$5.22B

Since IPO (2025)-34%

5 YearN/A

1 YearN/A

1 Month-3%

Caris Life Sciences Financials at a Glance

Market Cap

$5.22B

Revenue (TTM)

$812.03M

Net Income (TTM)

$68.09M

EPS (TTM)

$-1.92

P/E Ratio

-9.64

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$18.63

Volume

10,038

Open

$18.69

Price

$18.63

Volume

10,038

Open

$18.69

Previous Close

$18.47

Daily Range

$18.31 - $18.84

52-Week Range

$16.28 - $42.50

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$18.63

Volume

10,038

Open

$18.69

Previous Close

$18.47

Daily Range

$18.31 - $18.84

52-Week Range

$16.28 - $42.50

CAI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Caris Life Sciences

Industry

Biotechnology

Sector

Health Care

Employees

1,846

CEO

David Dean Halbert

Website

www.carislifesciences.com

Headquarters

Irving, TX 75039, US

CAI Financials

Key Financial Metrics (TTM)

Gross Margin

66%

Operating Margin

Net Income Margin

-8%

Return on Equity

-45%

Return on Capital

Return on Assets

-6%

Earnings Yield

-10.37%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.22B

Shares Outstanding

282.58M

Volume

10.04K

Avg. Volume

2.30M

Financials (TTM)

Gross Profit

$539.17M

Operating Income

$45.11M

EBITDA

$11.38M

Operating Cash Flow

$83.16M

Capital Expenditure

$16.26M

Free Cash Flow

$66.89M

Cash & ST Invst.

$800.09M

Total Debt

$378.99M

Caris Life Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$292.89M

+192.7%

Gross Profit

$220.91M

+488.3%

Gross Margin

75.43%

N/A

Market Cap

$5.22B

N/A

Market Cap/Employee

$2.95M

N/A

Employees

1,769

N/A

Net Income

$81.96M

+223.8%

EBITDA

$90.43M

+321.1%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$421.10M

+119.0%

Accounts Receivable

$112.14M

-41.2%

Inventory

$0.00

N/A

Long Term Debt

$378.82M

-81.9%

Short Term Debt

$169.00K

-99.9%

Return on Assets

-6.05%

N/A

Return on Invested Capital

4.52%

N/A

Free Cash Flow

$5.66M

+108.6%

Operating Cash Flow

$13.44M

+121.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CORTCorcept Therapeutics Incorporated

CORTCorcept Therapeutics Incorporated$51.43+0.02%

RYTMRhythm Pharmaceuticals, Inc.

RYTMRhythm Pharmaceuticals, Inc.$84.05+2.73%

MRUSMerus N.V.

MRUSMerus N.V.$90.00+0.00%

HALOHalozyme Therapeutics, Inc.

HALOHalozyme Therapeutics, Inc.$64.10+0.22%

ABVXAbivax S.A.

ABVXAbivax S.A.$116.21-1.19%

CYTKCytokinetics, Incorporated

CYTKCytokinetics, Incorporated$66.72+5.32%

RNAAtrium Therapeutics, Inc.

RNAAtrium Therapeutics, Inc.$13.18-1.86%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$8.46+2.66%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.93-0.01%

PNSkycorp Solar Group

PNSkycorp Solar Group$4.99+0.74%

NCLHNorwegian Cruise Line

NCLHNorwegian Cruise Line$17.25-0.08%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.86+0.03%

ADTADT

ADTADT$7.08-0.06%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.58+0.01%

Questions About CAI

What is the current price of Caris Life Sciences?

Caris Life Sciences is trading at $18.63 per share.

What is the 52-week range for Caris Life Sciences?

Over the past 52 weeks, Caris Life Sciences has traded between $16.28 and $42.50.

How much debt does Caris Life Sciences have?

As of the most recent reporting period, Caris Life Sciences reported total debt of $427.69M.

How much cash does Caris Life Sciences have on hand?

Caris Life Sciences reported $797.80M in cash and cash equivalents in its most recent financial results.

What is Caris Life Sciences’s dividend yield?

Caris Life Sciences does not currently have a dividend yield.

Caris Life Sciences

Caris Life Sciences Financials at a Glance

CAI News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Caris Life Sciences

CAI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Caris Life Sciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CAI

What is the current price of Caris Life Sciences?

What is the 52-week range for Caris Life Sciences?

How much debt does Caris Life Sciences have?

How much cash does Caris Life Sciences have on hand?

What is Caris Life Sciences’s dividend yield?

Premium Investing Services